Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases

@article{Vendetti2013EpigeneticTI,
  title={Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases},
  author={F. Vendetti and C. Rudin},
  journal={Expert Opinion on Biological Therapy},
  year={2013},
  volume={13},
  pages={1273 - 1285}
}
  • F. Vendetti, C. Rudin
  • Published 2013
  • Biology, Medicine
  • Expert Opinion on Biological Therapy
  • Introduction: Epigenetics refers to heritable modifications of DNA and associated chromatin components that influence gene expression without altering DNA coding sequence. Epigenetic dysregulation is a central contributor to oncogenesis and is increasingly a focus of interest in cancer therapeutic research. Two key levels of aberrant epigenetic control are DNA methylation and histone acetylation. Primary regulators of these epigenetic changes include DNA methyltransferases (DNMTs) and histone… CONTINUE READING
    50 Citations
    Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer
    • 7
    DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
    • 1
    • PDF
    The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent
    • 6
    • PDF
    Epigenetic alterations in cancer and personalized cancer treatment.
    • 24
    Nutri-epigenetics and synthetic analogs in cancer chemoprevention.
    • 6

    References

    SHOWING 1-10 OF 132 REFERENCES
    Epigenetic Modifications as Therapeutic Targets
    • 614
    Histone Deacetylase Inhibitors for Cancer Therapy
    • 564
    • Highly Influential
    Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
    • 269
    Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity
    • 177
    Targeting DNA Methylation
    • 339
    • Highly Influential
    • PDF
    Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line
    • 329
    • PDF
    DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
    • 1,175
    Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
    • 1,852
    • PDF